Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicki J Hwang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|September 20, 2016
Metabolomic profiling for early cancer detection: current status and future prospectsVicki J Hwang, Robert H Weiss
Biomarkers in Medicine|December 20, 2014
Biomarkers in IgA nephropathyVicki J Hwang, Arzu Ulu, Justin van Hoorebeke, et al.
BMC Medical Genetics|October 15, 2014
Mapping the deletion endpoints in individuals with 22q11.2 deletion syndrome by droplet digital PCRVicki J Hwang, Dianna Maar, John Regan, et al.
American Journal of Physiology. Renal Physiology|July 10, 2015
The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarateVicki J Hwang, Jeffrey Kim, Amy Rand, et al.
Plos One|August 2, 2014
Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndromeChantal Sellier, Vicki J Hwang, Ravi Dandekar, et al.
Kidney International|May 27, 2017
Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney diseaseVicki J Hwang, Xia Zhou, Xiaonan Chen, et al.
American Journal of Physiology. Renal Physiology|October 4, 2018
Arginine reprogramming in ADPKD results in arginine-dependent cystogenesisJosephine F Trott, Vicki J Hwang, Tatsuto Ishimaru, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Metabolism & Toxicology|September 20, 2016
Metabolomic profiling for early cancer detection: current status and future prospectsVicki J Hwang, Robert H Weiss
Biomarkers in Medicine|December 20, 2014
Biomarkers in IgA nephropathyVicki J Hwang, Arzu Ulu, Justin van Hoorebeke, et al.
BMC Medical Genetics|October 15, 2014
Mapping the deletion endpoints in individuals with 22q11.2 deletion syndrome by droplet digital PCRVicki J Hwang, Dianna Maar, John Regan, et al.
American Journal of Physiology. Renal Physiology|July 10, 2015
The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarateVicki J Hwang, Jeffrey Kim, Amy Rand, et al.
Plos One|August 2, 2014
Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndromeChantal Sellier, Vicki J Hwang, Ravi Dandekar, et al.
Kidney International|May 27, 2017
Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney diseaseVicki J Hwang, Xia Zhou, Xiaonan Chen, et al.
American Journal of Physiology. Renal Physiology|October 4, 2018
Arginine reprogramming in ADPKD results in arginine-dependent cystogenesisJosephine F Trott, Vicki J Hwang, Tatsuto Ishimaru, et al.
Pageof 1